Two clinical trials of a potential Alzheimer’s drug were halted this week, highlighting circulating skepticism about the hypothesis that amyloid beta plaque is a major factor in the disease’s genesis. [More]
Read more from the original source:
Halted Alzheimer’s drug trials renew questions about causes of the disease
Tags:
drug-were,
week,
a-major-factor,
major-factor,
clinical-trials,
disease,
the-hypothesis
Related posts:
- Alzheimer’s drug trials show promise
- FDA staff questions Lilly drug for Alzheimer’s test
- Alzheimer’s Association Prompts FDA to Broaden Trials
- Local clinical trials helping to improve Alzheimer’s treatment
- Alzheimer’s center will conduct clinical trials for two drugs
This entry was posted
on Sunday, August 22nd, 2010 at 2:34 am and is filed under Alzheimer's Disease.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.